{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:04:46Z","timestamp":1750737886390,"version":"3.41.0"},"reference-count":281,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.rgmxen.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:25:22Z","timestamp":1747229122000},"page":"252-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda) - AMNM (Asociaci\u00f3n Mexicana de Neurogastroenterolog\u00eda y Motilidad) expert joint review"],"prefix":"10.1016","volume":"90","author":[{"given":"O.","family":"G\u00f3mez-Escudero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Remes-Troche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Coss-Adame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Garc\u00eda-Zerme\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Aquino-Matus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jim\u00e9nez-Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.R.","family":"Valdovinos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Vargas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Amieva-Balmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Arenas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"F\u00e9lix-T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.","family":"G\u00f3mez-Casta\u00f1os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mej\u00eda-Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Valdovinos-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"V\u00e1zquez-Elizondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Villar-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Gyawali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2024.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-Functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0010","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (Disorders of Gut-Brain Interaction): A Rome Foundation working team report","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0020","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","article-title":"AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review","volume":"20","author":"Yadlapati","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0025","first-page":"121","article-title":"Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda","volume":"89","author":"Valdovinos-D\u00edaz","year":"2024","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.gtc.2018.07.002","article-title":"Brain-gut axis: clinical implications","volume":"47","author":"Khlevner","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2024.01.024","article-title":"Advances in brain-gut-microbiome interactions: a comprehensive update on signaling mechanisms, disorders, and therapeutic implications","volume":"18","author":"Dong","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11894-018-0664-3","article-title":"Psychotropics, Antidepressants, and visceral analgesics in functional gastrointestinal disorders","volume":"20","author":"T\u00f6rnblom","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0045","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The microbiota-gut-brain axis: from motility to mood","volume":"160","author":"Margolis","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.14309\/ajg.0000000000002800","article-title":"Central neuromodulators in irritable bowel syndrome: why, how, and when","volume":"119","author":"Hanna-Jairala","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ajg.2017.57","article-title":"Central neuromodulators for treating functional GI disorders: a primer","volume":"112","author":"Sobin","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0060","series-title":"Cl\u00ednicas Mexicanas de Gastroenterolog\u00eda, Farmacolog\u00eda Gastrointestinal I","first-page":"179","article-title":"Neuromoduladores: lo que el Gastroenter\u00f3logo debe saber","author":"G\u00f3mez-Escudero","year":"2024"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0065","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2021.07.037","article-title":"A Review of the evidence and recommendations on communication skills and the patient-provider relationship: A Rome Foundation working team report","volume":"161","author":"Drossman","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5056\/jnm23161","article-title":"Clinicians\u2019 knowledge, attitudes, and practices regarding the management of functional gastrointestinal disorders with neuromodulators and psychological treatment","volume":"30","author":"Shin","year":"2024","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0075","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0080","series-title":"Cl\u00ednicas Mexicanas de Gastroenterolog\u00eda, Farmacolog\u00eda Gastrointestinal I","first-page":"11","article-title":"Principios B\u00e1sicos de Farmacolog\u00eda: Lo Indispensable","author":"Asbun-Bojal","year":"2024"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1525-1403.2008.00172.x","article-title":"Neuromodulatory processes of the brain-gut axis","volume":"11","author":"Gaman","year":"2008","journal-title":"Neuromodulation"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0090","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.cgh.2021.07.006","article-title":"AGA clinical practice update on management of chronic gastrointestinal pain in disorders of gut-brain interaction: expert review","volume":"19","author":"Keefer","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.029","article-title":"Pharmacological, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders","author":"Camilleri","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00535-012-0726-5","article-title":"Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases","volume":"48","author":"Grover","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/j.1875-9114.1997.tb03674.x","article-title":"Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects","volume":"17","author":"Stimmel","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0110","first-page":"678","article-title":"Treatment of functional GI disorders with psychotropic medicines: a review of evidence with a practical approach","volume":"2","author":"Thiwan","year":"2006","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0115","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fphar.2018.00913","article-title":"A History of drug discovery for treatment of nausea and vomiting and the implications for future research","volume":"9","author":"Sanger","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cgh.2006.10.004","article-title":"Zonisamide or levetiracetam for adults with cyclic vomiting syndrome: a case series","volume":"5","author":"Clouse","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0125","article-title":"Ligandos alfa 2-delta: Pasado, presente y futuro","volume":"24","author":"Alc\u00e1ntara-Montero","year":"2016","journal-title":"Rev Soc Espa\u00f1ola del Dolor"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2016.1202764","article-title":"Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use","volume":"16","author":"Calandre","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/0973-1229.58825","article-title":"Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","volume":"8","author":"Andrade","year":"2010","journal-title":"Mens Sana Monogr"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/nmo.12509","article-title":"Centrally targeted pharmacotherapy for chronic abdominal pain","volume":"27","author":"T\u00f6rnblom","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2006.02724.x","article-title":"Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man","volume":"23","author":"Tack","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.apha.2015.11.002","article-title":"The pharmacology of visceral pain","volume":"75","author":"Johnson","year":"2016","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0155","doi-asserted-by":"crossref","first-page":"G130","DOI":"10.1152\/ajpgi.00266.2002","article-title":"Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health","volume":"284","author":"Chial","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0160","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","article-title":"Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia","volume":"10","author":"Tack","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0165","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2036.2008.03849.x","article-title":"Influence of buspirone on gastric sensorimotor function in man","volume":"28","author":"Oudenhove","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2036.2000.00742.x","article-title":"Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis","volume":"14","author":"Mansi","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2036.2002.01180.x","article-title":"Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia","volume":"16","author":"Distrutti","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12904-020-00559-4","article-title":"The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature","volume":"19","author":"Saudemont","year":"2020","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0185","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0190","doi-asserted-by":"crossref","first-page":"e2290","DOI":"10.1002\/brb3.2290","article-title":"Advances in topiramate as prophylactic treatment for migraine","volume":"11","author":"Hu","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0195","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5056\/jnm16035","article-title":"A New approach to the prophylaxis of cyclic vomiting: topiramate","volume":"22","author":"Sezer","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0200","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007938","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0205","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2016.02.012","article-title":"Functional Esophageal Disorders","volume":"150","author":"Aziz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0210","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon Consensus","volume":"67","author":"Gyawali","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nmo.13067","article-title":"Ambulatory reflux monitoring for diagnosis of gastro\u2010esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group","volume":"29","author":"Roman","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MOG.0000000000000846","article-title":"Recent insights on functional heartburn and reflux hypersensitivity","volume":"38","author":"Savarino","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/gutjnl-2023-330616","article-title":"Updates to the modern diagnosis of GERD: Lyon consensus 2.0","volume":"73","author":"Gyawali","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0230","first-page":"725","article-title":"Update on functional heartburn","volume":"13","author":"Yamasaki","year":"2017","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0235","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2018.04.030","article-title":"Management of Patients With Functional Heartburn","volume":"154","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0240","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/nmo.12313","article-title":"Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial","volume":"26","author":"Ostovaneh","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ajg.2015.413","article-title":"Imipramine for treatment of esophageal hypersensitivity and functional heartburn: a randomized placebo-controlled trial","volume":"111","author":"Limsrivilai","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.14740\/gr898e","article-title":"Gastroesophageal reflux disease associated with anxiety: efficacy and safety of fixed dose combination of amitriptyline and pantoprazole","volume":"10","author":"Faruqui","year":"2017","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0255","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.dld.2024.05.013","article-title":"Central neuromodulators for patients with functional esophageal disorders: A systematic review and meta-analysis","volume":"56","author":"Yeh","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0260","doi-asserted-by":"crossref","first-page":"843","DOI":"10.5152\/tjg.2021.20607","article-title":"Comparative efficacy of antidepressants for symptoms remission of gastroesophageal reflux: a bayesian network meta-analysis of randomized controlled trials","volume":"32","author":"Si","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5056\/jnm19146","article-title":"Diagnosis and Management of Functional Chest Pain in the Rome IV Era","volume":"25","author":"Fass","year":"2019","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0270","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2982.2000.00230.x","article-title":"Abnormal cerebral processing of oesophageal stimuli in patients with noncardiac chest pain (NCCP)","volume":"12","author":"Hollerbach","year":"2000","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/nmo.12339","article-title":"The role of pain modulators in esophageal disorders - no pain no gain","volume":"26","author":"Dickman","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0280","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/gut.42.6.807","article-title":"Imipramine decreases oesophageal pain perception in human male volunteers","volume":"42","author":"Peghini","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0285","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM199405193302003","article-title":"Imipramine in patients with chest pain despite normal coronary angiograms","volume":"330","author":"Cannon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0290","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3748\/wjg.v19.i30.4958","article-title":"Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain","volume":"19","author":"Park","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0295","first-page":"6","article-title":"Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain","volume":"36","author":"Voulgaris","year":"2023","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0300","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1023\/A:1026645914933","article-title":"Long-term outcome from tricyclic antidepressant treatment of functional chest pain","volume":"44","author":"Prakash","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2000.108514","article-title":"Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin","volume":"140","author":"Varia","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0310","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.pain.2010.08.040","article-title":"Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study","volume":"152","author":"Keefe","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0315","first-page":"15","article-title":"A randomized controlled trial of paroxetine for noncardiac chest pain","volume":"39","author":"Doraiswamy","year":"2006","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jpsychores.2010.02.005","article-title":"Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine","volume":"69","author":"Spinhoven","year":"2010","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0325","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2036.2006.02772.x","article-title":"Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study","volume":"23","author":"Broekaert","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0330","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/apt.13015","article-title":"Systematic review with meta-analysis: selective serotonin reuptake inhibitors for noncardiac chest pain","volume":"41","author":"Atluri","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0335","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/ajg.2010.82","article-title":"Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial","volume":"105","author":"Lee","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0340","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2036.2011.04978.x","article-title":"Systematic review: the treatment of noncardiac chest pain with antidepressants","volume":"35","author":"Nguyen","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/2050640613499567","article-title":"A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders","volume":"1","author":"Lahner","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0350","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0016-5085(87)90979-6","article-title":"Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial","volume":"92","author":"Clouse","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0355","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00004836-199904000-00008","article-title":"Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach","volume":"28","author":"Handa","year":"1999","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0360","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2036.2011.04955.x","article-title":"Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study","volume":"35","author":"Chua","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0365","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/000348941312200803","article-title":"Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin","volume":"122","author":"Kirch","year":"2013","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0370","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5056\/jnm17097","article-title":"Reflux hypersensitivity: a new functional esophageal disorder","volume":"23","author":"Yamasaki","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0375","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1756283X11409279","article-title":"Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus","volume":"4","author":"Viazis","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0380","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/nmo.12251","article-title":"Effect of nortriptyline on brain responses to painful esophageal acid infusion in patients with non-erosive reflux disease","volume":"26","author":"Forcelini","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0385","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3748\/wjg.v18.i20.2462","article-title":"Globus pharyngeus: a review of its etiology, diagnosis and treatment","volume":"18","author":"Lee","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0390","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00405-020-06544-0","article-title":"Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs)","volume":"278","author":"Takahashi","year":"2021","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0395","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.3748\/wjg.v19.i42.7455","article-title":"Effect of low-dose amitriptyline on globus pharyngeus and its side effects","volume":"19","author":"You","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0400","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1131354","article-title":"Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders","volume":"14","author":"Alkhowaiter","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0405","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2015-310721","article-title":"Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis","volume":"66","author":"Ford","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0410","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00535-005-1687-8","article-title":"Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review","volume":"40","author":"Hojo","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0415","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","article-title":"Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia","volume":"93","author":"Mertz","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0420","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1572-0241.2008.02021.x","article-title":"Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial","volume":"103","author":"Bouras","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0425","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2036.2011.04775.x","article-title":"Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study","volume":"34","author":"Braak","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0430","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.04.020","article-title":"Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study","volume":"149","author":"Talley","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0435","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10620-020-06191-9","article-title":"Effects of Low-Dose Amitriptyline on Epigastric Pain Syndrome in Functional Dyspepsia Patients","volume":"66","author":"Liu","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0440","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2468-1253(18)30303-0","article-title":"Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Cheong","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0445","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jgh.13914","article-title":"Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial","volume":"33","author":"Kaosombatwattana","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0450","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5056\/jnm23147","article-title":"Clinical Trial: Efficacy of Mosapride Controlled-release and Nortriptyline in Patients With Functional Dyspepsia: A Multicenter, Double-placebo, Double-blinded, Randomized Controlled, Parallel Clinical Study","volume":"30","author":"Tae","year":"2024","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0455","first-page":"468","article-title":"Comparison of the potency of nortriptyline and mirtazapine on gastrointestinal symptoms, the level of anxiety and depression in patients with functional dyspepsia","volume":"16","author":"Jamshidfar","year":"2023","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0460","first-page":"448","article-title":"A randomized clinical trial of metacognitive therapy and nortriptyline for anxiety, depression, and difficulties in emotion regulation of patients with functional dyspepsia","volume":"23","author":"Batebi","year":"2020","journal-title":"Res Psychother"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0465","article-title":"Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia - a randomized clinical trial","volume":"14","author":"Banihashem","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0470","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.16072","article-title":"Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia","volume":"53","author":"Ford","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0475","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2169\/internalmedicine.9099-17","article-title":"A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia","volume":"56","author":"Hojo","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0480","article-title":"Comparative efficacy and acceptability of psychotropic drugs for functional dyspepsia in adults: A systematic review and network meta-analysis","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0485","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.3748\/wjg.v18.i42.6127","article-title":"Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study","volume":"18","author":"Tan","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0490","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.3748\/wjg.v22.i22.5260","article-title":"Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss","volume":"22","author":"Jiang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110266","article-title":"Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis","volume":"109","author":"Oliva","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0500","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","article-title":"Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial","volume":"6","author":"van Kerkhoven","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0505","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","article-title":"Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss","volume":"14","author":"Tack","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0510","doi-asserted-by":"crossref","first-page":"489","DOI":"10.23736\/S0026-4806.17.05320-4","article-title":"Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a \u201creal world\u201d study by 13C-octanoic Acid Breath Test","volume":"108","author":"Caviglia","year":"2017","journal-title":"Minerva Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0515","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1038\/ajg.2009.427","article-title":"Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial","volume":"104","author":"Miwa","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0520","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10620-022-07717-z","article-title":"Clinical Efficacy of Tandospirone on Functional Dyspepsia Patients with Anxiety: A Randomized, Placebo-Controlled Study","volume":"68","author":"Liu","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3904\/kjim.1998.13.1.15","article-title":"Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying","volume":"13","author":"Song","year":"1998","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0530","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1542-3565(04)00059-X","article-title":"Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial","volume":"2","author":"Mearin","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0535","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10620-009-0723-6","article-title":"Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders","volume":"54","author":"Grover","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0540","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.14309\/ajg.0000000000002216","article-title":"Diagnosis and Management of Cyclic Vomiting Syndrome: A Critical Review","volume":"118","author":"Frazier","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0545","first-page":"349","article-title":"Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting","volume":"97","author":"Chanthawong","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0550","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/apt.16588","article-title":"Randomised clinical trial: the effects of pregabalin vs placebo on functional dyspepsia","volume":"54","author":"Kotikula","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0555","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/abr.abr_234_18","article-title":"Evaluating the Effect of Oral Gabapentin on the Improvement of Gastrointestinal Symptoms in Patients with Functional Dyspepsia Resistant to Conventional Treatments","volume":"8","author":"Shafigh-Ardestani","year":"2019","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0560","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MCG.0000000000001034","article-title":"Gabapentin Improves Symptoms of Functional Dyspepsia in a Retrospective, Open-label Cohort Study","volume":"53","author":"Staller","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0565","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.14309\/ajg.0000000000001874","article-title":"ACG Clinical Guideline: Gastroparesis","volume":"117","author":"Camilleri","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0570","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s10620-019-05522-9","article-title":"Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life","volume":"64","author":"Parkman","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0575","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1136\/gutjnl-2019-318712","article-title":"Gastroparesis: a turning point in understanding and treatment","volume":"68","author":"Grover","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0580","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1053\/j.gastro.2021.01.230","article-title":"Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features","volume":"160","author":"Pasricha","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0585","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MCG.0000000000000728","article-title":"Gastroparesis: Quality of Life and Health Care Utilization","volume":"52","author":"Lacy","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0590","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cgh.2010.04.027","article-title":"Abdominal pain is a frequent symptom of gastroparesis","volume":"8","author":"Cherian","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0595","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1023\/A:1018878324327","article-title":"Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients","volume":"43","author":"Prakash","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0600","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10620-006-9378-8","article-title":"Tricyclic antidepressants for chronic vomiting in diabetic patients","volume":"52","author":"Sawhney","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0605","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1001\/jama.2013.282833","article-title":"Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial","volume":"310","author":"Parkman","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0610","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3748\/wjg.v26.i19.2333","article-title":"Gastroparesis: New insights into an old disease","volume":"26","author":"Usai-Satta","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0615","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0620","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/apt.17466","article-title":"Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis","volume":"57","author":"Sanger","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0625","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1176\/appi.psy.47.5.440","article-title":"Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment","volume":"47","author":"Kim","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0630","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000256","article-title":"Mirtazapine for Refractory Gastroparesis","volume":"6","author":"Marella","year":"2019","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0635","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.3748\/wjg.v20.i21.6671","article-title":"Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine","volume":"20","author":"Kundu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0640","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2147\/DDDT.S125743","article-title":"Mirtazapine for symptom control in refractory gastroparesis","volume":"11","author":"Malamood","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0645","article-title":"Mirtazapine: A one-stop strategy for treatment of opioid withdrawal symptoms","volume":"15","author":"Lalani","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0650","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diacare.20.1.55","article-title":"Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis","volume":"20","author":"Melga","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0655","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.gastrohep.2010.07.002","article-title":"[Levosulpiride in the management of functional dyspepsia and delayed gastric emptying]","volume":"33","author":"Serra","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2023.102395","article-title":"Pharmacologic treatment of gastroparesis: What is (still) on the horizon?","volume":"72","author":"Schweckendiek","year":"2023","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0665","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/apt.17479","article-title":"Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST)","volume":"57","author":"Parkman","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0670","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMsa0906126","article-title":"Outcome reporting in industry-sponsored trials of gabapentin for off-label use","volume":"361","author":"Vedula","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0675","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0680","article-title":"Pregabalin for neuropathic pain in adults","volume":"1","author":"Derry","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0685","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12876-022-02372-0","article-title":"A cross-sectional study describing peripheral neuropathy in patients with symptoms of gastroparesis: associations with etiology, gastrointestinal symptoms, and gastric emptying","volume":"22","author":"Moors","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.rgmxen.2024.12.001_bib0690","article-title":"Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association","volume":"31","author":"Venkatesan","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0695","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.gastro.2024.05.031","article-title":"AGA clinical practice update on diagnosis and management of cyclic vomiting syndrome: Commentary","volume":"167","author":"Levinthal","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0700","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal Disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0705","first-page":"389","article-title":"Cyclic vomiting syndrome: From pathophysiology to treatment","volume":"89","author":"Jim\u00e9nez-Castillo","year":"2024","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0710","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/j.1572-0241.1999.01428.x","article-title":"Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants","volume":"94","author":"Prakash","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0715","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MCG.0b013e3181ac6489","article-title":"Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two-year follow-up study","volume":"44","author":"Hejazi","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0720","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3748\/wjg.v13.i12.1833","article-title":"Cyclic vomiting syndrome in children: experience with 181 cases from southern Iran","volume":"13","author":"Haghighat","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0725","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ajg.2017.194","article-title":"Prophylactic therapy of cyclic vomiting syndrome in children: comparison of amitriptyline and cyproheptadine: a randomized clinical trial","volume":"113","author":"Badihian","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0730","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13605","article-title":"Management of cyclic vomiting syndrome in adults: Evidence review","volume":"31","author":"Sharaf","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0735","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/17474124.2019.1691527","article-title":"Cyclic vomiting syndrome: an overview for clinicians","volume":"13","author":"Herlihy","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0740","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-230X-12-52","article-title":"Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms--pediatric versus adult?","volume":"12","author":"Kumar","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0745","first-page":"1077","article-title":"Short- and long-term outcomes of children with cyclic vomiting syndrome","volume":"97","author":"Treepongkaruna","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0750","doi-asserted-by":"crossref","first-page":"965","DOI":"10.14309\/ajg.0000000000002628","article-title":"Epidemiology, comorbidities, and treatment of cyclic vomiting syndrome in the United States","volume":"119","author":"Chen","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0755","first-page":"KC01","article-title":"Impact of amitryptiline on migraine disability assessment score","volume":"8","author":"Moras","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0760","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/apt.16457","article-title":"Retrospective review of patients treated for cyclic vomiting syndrome with topiramate","volume":"54","author":"Mooers","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0765","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcph.2374","article-title":"Treatment options for cyclic vomiting syndrome: a real-world, single-center experience with systematic literature review and meta-analysis","volume":"64","author":"Falsaperla","year":"2024","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0770","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5056\/jnm.2011.17.3.305","article-title":"Psychiatric co-morbidity and efficacy of mirtazapine treatment in young subjects with chronic or cyclic vomiting syndromes: a case series","volume":"17","author":"Coskun","year":"2011","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0775","article-title":"Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults","volume":"9","author":"Sutherland","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0780","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11938-016-0110-2","article-title":"Newest drugs for chronic unexplained nausea and vomiting","volume":"14","author":"Hasler","year":"2016","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0785","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11938-016-0113-z","article-title":"Chronic unexplained nausea and vomiting or gastric neuromuscular dysfunction (GND)? An update on nomenclature, pathophysiology and treatment, and relationship to gastroparesis","volume":"14","author":"Harer","year":"2016","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0790","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MCG.0000000000001164","article-title":"Practical perspectives in the treatment of nausea and vomiting","volume":"53","author":"Cangemi","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0795","first-page":"506","article-title":"Chronic nausea and vomiting syndrome and impact on quality of life","volume":"89","author":"F\u00e9lix-T\u00e9llez","year":"2024","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0800","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.pnpbp.2006.03.015","article-title":"Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting","volume":"30","author":"Pae","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0805","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jopan.2018.11.006","article-title":"Mirtazapine for postoperative nausea and vomiting: systematic review, meta-analysis, and trial sequential analysis","volume":"34","author":"Bhattacharjee","year":"2019","journal-title":"J Perianesth Nurs"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0810","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0885-3924(95)00105-8","article-title":"Effectiveness of levosulpiride versus metoclopramide for nausea and vomiting in advanced cancer patients: a double-blind, randomized, crossover study","volume":"10","author":"Corli","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0815","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/08258597211013952","article-title":"The use of quetiapine for the management of nausea and vomiting in idiopathic Parkinson\u2019s disease","volume":"37","author":"Hindmarsh","year":"2022","journal-title":"J Palliat Care"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0820","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00482-012-1216-7","article-title":"Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients: a review","volume":"26","author":"Benze","year":"2012","journal-title":"Schmerz"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0825","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/postgradmedj-2012-131284","article-title":"Sensory neuromodulators in functional nausea and vomiting: predictors of response","volume":"89","author":"Patel","year":"2013","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0830","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00221-014-3905-1","article-title":"Gabapentin\u2019s anti-nausea and anti-emetic effects: a review","volume":"232","author":"Guttuso","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0835","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.gastro.2023.04.039","article-title":"AGA clinical practice update on evaluation and management of belching, abdominal bloating, and distention: expert review","volume":"165","author":"Moshiree","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0840","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cgh.2017.10.038","article-title":"Diaphragmatic breathing reduces belching and proton pump inhibitor refractory gastroesophageal reflux symptoms","volume":"16","author":"Ong","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0845","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/ajg.2018.15","article-title":"Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux","volume":"113","author":"Glasinovic","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0850","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00455-018-9890-y","article-title":"Speech therapy as treatment for supragastric belching","volume":"33","author":"Cate","year":"2018","journal-title":"Dysphagia"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0855","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cgh.2011.10.042","article-title":"Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching","volume":"10","author":"Blondeau","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0860","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14315","article-title":"The clinical value of psycho-gastroenterological interventions for functional esophageal symptoms","volume":"34","author":"Hurtte","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0865","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/flgastro-2021-101856","article-title":"Rumination syndrome: pathophysiology, diagnosis and practical management","volume":"13","author":"Sasegbon","year":"2022","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0870","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12954","article-title":"Rumination syndrome: pathophysiology, diagnosis, and treatment","volume":"29","author":"Absah","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0875","doi-asserted-by":"crossref","first-page":"562","DOI":"10.14309\/ajg.0000000000000060","article-title":"Diagnosis and treatment of rumination syndrome: a critical review","volume":"114","author":"Murray","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0880","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/nmo.12737","article-title":"Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action","volume":"28","author":"Halland","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0885","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjms.2020.04.003","article-title":"Outcomes of treating rumination syndrome with a tricyclic antidepressant and diaphragmatic breathing","volume":"360","author":"Robles","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0890","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/ajg.2009.341","article-title":"Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms","volume":"104","author":"Drossman","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0895","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mic\u00f3","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0900","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/JCP.0000000000000599","article-title":"An open-label pilot study of duloxetine in patients with irritable bowel syndrome and comorbid major depressive disorder","volume":"36","author":"Lewis-Fern\u00e1ndez","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0905","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231152334","article-title":"Randomized clinical trial: the effects of pregabalin for centrally mediated abdominal pain syndrome","volume":"16","author":"Xu","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0910","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cgh.2007.06.013","article-title":"The narcotic bowel syndrome: clinical features, pathophysiology, and management","volume":"5","author":"Grunkemeier","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0915","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with constipation","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0920","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0925","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis","volume":"114","author":"Ford","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0930","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","article-title":"Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Ford","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0935","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2004.04127.x","article-title":"Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial","volume":"99","author":"Tabas","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0940","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2036.2005.02566.x","article-title":"The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study","volume":"22","author":"Vahedi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0945","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cgh.2009.09.008","article-title":"Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome","volume":"8","author":"Ladabaum","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0950","article-title":"Efficacy and safety of antidepressants for the treatment of irritable bowel syndrome: a meta-analysis","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0955","article-title":"A systematic review on the efficacy and safety of selective serotonin reuptake inhibitors in gastrointestinal motility disorders: more control, less risk","volume":"14","author":"Acharekar","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0960","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hup.1038","article-title":"Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study","volume":"24","author":"Brennan","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0965","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/13651501.2013.838632","article-title":"An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder","volume":"18","author":"Kaplan","year":"2014","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0970","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/gut.2006.110858","article-title":"Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome","volume":"56","author":"Houghton","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0975","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.dld.2013.09.002","article-title":"Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome","volume":"46","author":"Iturrino","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0980","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/apt.15077","article-title":"Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome","volume":"49","author":"Saito","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0985","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cgh.2020.03.056","article-title":"Management of chronic abdominal distension and bloating","volume":"19","author":"Lacy","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0990","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14333","article-title":"Management of bloating","volume":"34","author":"Serra","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib0995","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ajg.2017.458","article-title":"Effects of antidepressants on gastric function in patients with functional dyspepsia","volume":"113","author":"Lacy","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1000","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.009","article-title":"Functional anorectal disorders","author":"Rao","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1005","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3949\/ccjm.89a.21102","article-title":"Chronic anal pain: A review of causes, diagnosis, and treatment","volume":"89","author":"Knowles","year":"2022","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15403\/jgld-4090","article-title":"Neuromodulators in the brain-gut axis: their role in the therapy of the irritable bowel syndrome","volume":"30","author":"Stanculete","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3389\/fpsyt.2020.00797","article-title":"Placebo responses and placebo effects in functional gastrointestinal disorders","volume":"11","author":"Enck","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5114\/aoms.2019.86928","article-title":"Effects of antidepressants on QT interval in people with mental disorders","volume":"16","author":"Aronow","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.111.183285","article-title":"Drug discontinuation effects are part of the pharmacology of a drug","volume":"339","author":"Reidenberg","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40263-022-00960-y","article-title":"Estimating risk of antidepressant withdrawal from a review of published data","volume":"37","author":"Horowitz","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1045","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.3390\/jcm12124113","article-title":"The biology of placebo and nocebo effects on experimental and chronic pain: state of the art","volume":"12","author":"Rossettini","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1050","first-page":"1245","article-title":"Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis","volume":"159","author":"Trindade","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1055","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1038\/s41598-022-18654-2","article-title":"Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis","volume":"12","author":"Alam","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008341","article-title":"Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study","volume":"5","author":"Patel","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bja.2021.08.032","article-title":"Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials","volume":"128","author":"Wang","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1533-2500.2004.04304.x","article-title":"Side effects of antiepileptics--a review","volume":"4","author":"Walia","year":"2004","journal-title":"Pain Pract"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1075","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1472-8206.1998.tb00976.x","article-title":"Serotonin syndrome: history and risk","volume":"12","author":"Gillman","year":"1998","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bcpt.13912","article-title":"Serotonin syndrome-A focused review","volume":"133","author":"Mikkelsen","year":"2023","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/15563650.2021.1993242","article-title":"The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes","volume":"60","author":"Chiew","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1090","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14894","article-title":"A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut-brain interaction","volume":"36","author":"Ballou","year":"2024","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1095","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1252268","article-title":"Patients functional gastrointestinal disorders-importance of communication between physician and patient assessed in a cross-sectional cohort with study","volume":"14","author":"Goebel-Stengel","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1100","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MLR.0b013e31819a5acc","article-title":"Physician communication and patient adherence to treatment: a meta-analysis","volume":"47","author":"Zolnierek","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1105","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s11606-019-05525-2","article-title":"Can patient-provider interpersonal interventions achieve the quadruple aim of healthcare? A systematic review","volume":"35","author":"Haverfield","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.gastrohep.2018.05.009","article-title":"Hospital Anxiety and Depression Scale (HADS): Validation in Mexican Patients with Inflammatory Bowel Disease","volume":"41","author":"Yamamoto-Furusho","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1115","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1120","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14161","article-title":"Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome","volume":"33","author":"Snijkers","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","article-title":"Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment","volume":"19","author":"Bisgaard","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1130","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41575-023-00794-z","article-title":"Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management","volume":"20","author":"Staudacher","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"year":"2022","series-title":"The Maudsley prescribing guidelines in psychiatry","author":"Taylor","key":"10.1016\/j.rgmxen.2024.12.001_bib1135"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/ajp.145.11.1358","article-title":"Somatization: the concept and its clinical application","volume":"145","author":"Lipowski","year":"1988","journal-title":"Am J Psychiatry"},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders","key":"10.1016\/j.rgmxen.2024.12.001_bib1145"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1073191117721740","article-title":"Assessment of somatization and medically unexplained symptoms in later life","volume":"25","author":"van Driel","year":"2018","journal-title":"Assessment"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.genhosppsych.2020.03.004","article-title":"Distinct associations of DSM-5 somatic symptom disorder, diagnostic criteria for psychosomatic research-revised (DCPR-R) and symptom severity in patients with irritable bowel syndrome","volume":"64","author":"Porcelli","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jpsychores.2013.03.093","article-title":"How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires","volume":"74","author":"Zijlema","year":"2013","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1165","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1186\/s12913-024-11130-9","article-title":"Integrated care model for patients with functional somatic symptom disorder - a co-produced stakeholder exploration with recommendations for best practice","volume":"24","author":"R\u00f6hricht","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1170","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.gtc.2021.03.006","article-title":"Behavioral strategies for irritable bowel syndrome: Brain-Gut or Gut-Brain?","volume":"50","author":"Jagielski","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.gastro.2020.06.099","article-title":"Behavioral and diet therapies in integrated care for patients with irritable bowel syndrome","volume":"160","author":"Chey","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2021.09.015","article-title":"A Rome working team report on brain-gut behavior therapies for disorders of gut-brain interaction","volume":"162","author":"Keefer","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1185","article-title":"Irritable bowel syndrome: treating the gut and brain\/mind at the same time","volume":"15","author":"Jayasinghe","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1190","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.cgh.2024.03.004","article-title":"Behavioral therapy for functional heartburn: recommendation statements","volume":"22","author":"Guadagnoli","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1195","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/jcm10050915","article-title":"Appropriate number of treatment sessions in virtual reality-based individual cognitive behavioral therapy for social anxiety disorder","volume":"10","author":"Jeong","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1200","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","article-title":"Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1205","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(84)92793-4","article-title":"Controlled Trial Of Hypnotherapy In The Treatment Of Severe Refractory Irritable-Bowel Syndrome","volume":"324","author":"Whorwell","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00029157.2005.10401481","article-title":"Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action","volume":"47","author":"Tan","year":"2005","journal-title":"Am J Clin Hypn"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(18)30310-8","article-title":"Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial","volume":"4","author":"Flik","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/00207140500322933","article-title":"Standardized hypnosis treatment for irritable bowel syndrome: the North Carolina protocol","volume":"54","author":"Palsson","year":"2006","journal-title":"Int J Clin Exp Hypn"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00029157.2015.1025355","article-title":"Hypnotherapy for Esophageal Disorders","volume":"58","author":"Riehl","year":"2015","journal-title":"Am J Clin Hypn"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1230","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/140724","article-title":"Mindfulness-based therapies in the treatment of functional gastrointestinal disorders: a meta-analysis","volume":"2014","author":"Aucoin","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1235","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fpsyt.2020.00286","article-title":"Psychotherapeutic interventions in irritable bowel syndrome","volume":"11","author":"Hetterich","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1240","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1037\/0022-006X.72.6.1100","article-title":"Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis","volume":"72","author":"Lackner","year":"2004","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1245","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2024.05.010","article-title":"Effect of brain-gut behavioral treatments on abdominal pain in irritable bowel syndrome: systematic review and network meta-analysis","volume":"167","author":"Goodoory","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00406-020-01209-9","article-title":"Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry","volume":"271","author":"Elyamany","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1255","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/17474124.2023.2288156","article-title":"Noninvasive electrical neuromodulation for gastrointestinal motility disorders","volume":"17","author":"Yin","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1260","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fncel.2017.00214","article-title":"Transcranial alternating current stimulation (tACS) mechanisms and protocols","volume":"11","author":"Tavakoli","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1265","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3389\/fnins.2019.01218","article-title":"Transcranial direct current stimulation to improve the dysfunction of descending pain modulatory system related to opioids in chronic non-cancer pain: an integrative review of neurobiology and meta-analysis","volume":"13","author":"Zortea","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1270","doi-asserted-by":"crossref","first-page":"G700","DOI":"10.1152\/ajpgi.00426.2020","article-title":"Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia by enhancing vagal efferent activity","volume":"320","author":"Zhu","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1275","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2217\/pmt-2020-0067","article-title":"Noninvasive vagal nerve stimulation for gastroenterology pain disorders","volume":"11","author":"Gottfried-Blackmore","year":"2021","journal-title":"Pain Manag"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1280","doi-asserted-by":"crossref","first-page":"521","DOI":"10.14309\/ajg.0000000000002548","article-title":"Transcutaneous auricular vagal nerve stimulation is effective for the treatment of functional dyspepsia: a multicenter, randomized controlled study","volume":"119","author":"Shi","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1285","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1365-2982.2008.01164.x","article-title":"Transcutaneous electroacupuncture improves dyspeptic symptoms and increases high frequency heart rate variability in patients with functional dyspepsia","volume":"20","author":"Liu","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1290","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/832523","article-title":"An alternative to current therapies of functional dyspepsia: self-administrated transcutaneous electroacupuncture improves dyspeptic symptoms","volume":"2014","author":"Ji","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5056\/jnm16097","article-title":"Central and peripheral effects of transcutaneous acupuncture treatment for nausea in patients with diabetic gastroparesis","volume":"23","author":"Sarosiek","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1300","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13769","article-title":"Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis","volume":"32","author":"Gottfried-Blackmore","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1305","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.14309\/ajg.0000000000001882","article-title":"Transcutaneous electrical acustimulation improves irritable bowel syndrome with constipation by accelerating colon transit and reducing rectal sensation using autonomic mechanisms","volume":"117","author":"Huang","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1310","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150052","article-title":"Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation","volume":"6","author":"Shi","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1315","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/BF02234695","article-title":"Effect of sacral nerve stimulation in patients with fecal and urinary incontinence","volume":"44","author":"Leroi","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1320","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.cgh.2017.08.023","article-title":"Surgical interventions and the use of device-aided therapy for the treatment of fecal incontinence and defecatory disorders","volume":"15","author":"Bharucha","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1325","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/DCR.0b013e3181c7642c","article-title":"Sacral nerve stimulation is a valid approach in fecal incontinence due to sphincter lesions when compared to sphincter repair","volume":"53","author":"Ratto","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1330","article-title":"Sacral nerve stimulation for faecal incontinence and constipation in adults","volume":"2015","author":"Thaha","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1335","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(15)60314-2","article-title":"Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial","volume":"386","author":"Knowles","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1340","doi-asserted-by":"crossref","first-page":"162","DOI":"10.14309\/ajg.0000000000000766","article-title":"Translumbosacral neuromodulation therapy for fecal incontinence: a randomized frequency response trial","volume":"116","author":"Rao","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1345","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.gtc.2022.07.011","article-title":"Behavioral digital therapeutics in gastrointestinal conditions: Where are we now and where should we go?","volume":"51","author":"Greywoode","year":"2022","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1350","unstructured":"AAP Advisor. The App Evaluation Model [Accessed 23 October 2024]. Available from: https:\/\/www.psychiatry.org\/psychiatrists\/practice\/mental-health-apps\/the-app-evaluation-model#clinical."},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1355","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamainternmed.2022.3178","article-title":"Patient-centered pain care using artificial intelligence and mobile health tools","volume":"182","author":"Piette","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1360","first-page":"86","article-title":"Virtual reality: A new treatment paradigm for disorders of gut-brain interaction?","volume":"19","author":"Lacy","year":"2023","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1365","doi-asserted-by":"crossref","first-page":"210","DOI":"10.14309\/ajg.0000000000002492","article-title":"Virtual reality improves symptoms of functional dyspepsia: results of a randomized, double-blind, sham-controlled, pilot study","volume":"119","author":"Cangemi","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1370","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11894-024-00940-w","article-title":"The role of virtual reality in the management of irritable bowel syndrome","volume":"26","author":"Suchak","year":"2024","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1375","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nn.2726","article-title":"Anatomically distinct dopamine release during anticipation and experience of peak emotion to music","volume":"14","author":"Salimpoor","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1380","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tics.2013.02.007","article-title":"The neurochemistry of music","volume":"17","author":"Chanda","year":"2013","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1515\/revneuro-2021-0135","article-title":"Music affects functional brain connectivity and is effective in the treatment of neurological disorders","volume":"33","author":"Speranza","year":"2022","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1390","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jpain.2022.01.003","article-title":"Isn\u2019t there room for music in chronic pain management?","volume":"23","author":"Sihvonen","year":"2022","journal-title":"J Pain"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12906-022-03832-6","article-title":"Effects of music therapy as an alternative treatment on depression in children and adolescents with ADHD by activating serotonin and improving stress coping ability","volume":"23","author":"Park","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1400","doi-asserted-by":"crossref","first-page":"574","DOI":"10.5152\/tjg.2018.18200","article-title":"Evaluation of pain and patient satisfaction by music therapy in patients with endoscopy\/colonoscopy","volume":"29","author":"Bashiri","year":"2018","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2024.12.001_bib1405","doi-asserted-by":"crossref","first-page":"597","DOI":"10.36076\/ppj\/2017.7.597","article-title":"Music-induced analgesia in chronic pain conditions: a systematic review and meta-analysis","volume":"20","author":"Garza-Villarreal","year":"2017","journal-title":"Pain Physician"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:24:16Z","timestamp":1750692256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X25000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":281,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2255534X25000076"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2024.12.001","relation":{},"ISSN":["2255-534X"],"issn-type":[{"type":"print","value":"2255-534X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda) - AMNM (Asociaci\u00f3n Mexicana de Neurogastroenterolog\u00eda y Motilidad) expert joint review","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2024.12.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}